We are analyzing https://link.springer.com/article/10.1007/s12185-011-0996-3.

Title:
Mutations in epigenetic regulators in myelodysplastic syndromes | International Journal of Hematology
Description:
Until recently, the genetic aberrations that are causally linked to the pathogenesis of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms were largely unknown. Using novel technologies like high-resolution SNP-array analysis and next generation sequencing, various genes have now been identified that are recurrently mutated. Strikingly, several of the newly identified genes (ASXL1, DNMT3A, EZH2, IDH1 and IDH2, and TET2) are involved in the epigenetic regulation of gene expression. Aberrant epigenetic modifications have been described in many types of cancer, including myeloid malignancies. It has been proposed that repression of genes that are crucial for the cessation of the cell cycle and induction of differentiation might contribute to the malignant transformation of normal hematopoietic cells. Several therapies that aim to re-express silenced genes are currently being tested in MDS, like histone deacetylase inhibitors and hypomethylating agents. It will be interesting to assess whether patients carrying mutations in epigenetic regulators respond differently to these novel forms of epigenetic therapies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,603,724 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

article, pubmed, google, scholar, cas, mutations, myelodysplastic, syndromes, leukemia, dna, idh, myeloid, tet, cancer, genes, asxl, patients, acute, epigenetic, cell, dnmta, gene, hematopoietic, methylation, ezh, mds, histone, shen, nature, methyltransferase, human, nat, privacy, cookies, content, journal, hematology, nikoloski, cells, access, syndrome, prognostic, oncol, med, blood, stem, genet, publish, search, regulators,

Topics {✒️}

high-resolution snp-array analysis month download article/chapter α-ketoglutarate-dependent dioxygenases high-risk myelodysplastic syndrome retinoic acid receptor van der reijden & joop human b-cell lymphomas article international journal aberrant dna methylation full article pdf hematopoietic stem cells acute myeloid leukemias privacy choices/manage cookies dna- binding activity dna methyltransferase dnmt3a van der reijden dna methyltransferase inhibitors tet-mediated formation ligand-dependent coactivator normal hematopoietic cells sex-specific windows low-grade gliomas aberrant epigenetic modifications gene mutation patterns epigenetic regulation n-terminal domain pleiotropic hematopoietic abnormalities natl cancer inst human fetal gonads mansat-de mas metabolite 2-hydroxyglutarate accumulates fibroblast cells suggest histone deacetylase inhibitors mammalian dna methyltransferases article nikoloski icf syndrome mutations acute myeloid leukemia european economic area garcia-manero epigenetics cho ys additional sex comb chronic myelomonocytic leukaemia commonly reported variant cell stem cell hidalgo-curtis ce molecular findings management mayo clinic study patnaik mm mll partner tet1

Questions {❓}

How much?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Mutations in epigenetic regulators in myelodysplastic syndromes
         description:Until recently, the genetic aberrations that are causally linked to the pathogenesis of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms were largely unknown. Using novel technologies like high-resolution SNP-array analysis and next generation sequencing, various genes have now been identified that are recurrently mutated. Strikingly, several of the newly identified genes (ASXL1, DNMT3A, EZH2, IDH1 and IDH2, and TET2) are involved in the epigenetic regulation of gene expression. Aberrant epigenetic modifications have been described in many types of cancer, including myeloid malignancies. It has been proposed that repression of genes that are crucial for the cessation of the cell cycle and induction of differentiation might contribute to the malignant transformation of normal hematopoietic cells. Several therapies that aim to re-express silenced genes are currently being tested in MDS, like histone deacetylase inhibitors and hypomethylating agents. It will be interesting to assess whether patients carrying mutations in epigenetic regulators respond differently to these novel forms of epigenetic therapies.
         datePublished:2012-01-11T00:00:00Z
         dateModified:2012-01-11T00:00:00Z
         pageStart:8
         pageEnd:16
         sameAs:https://doi.org/10.1007/s12185-011-0996-3
         keywords:
            Myelodysplastic syndromes
            Mutations
            Epigenetic regulators
            Epigenetic therapy
            Hematology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12185-011-0996-3/MediaObjects/12185_2011_996_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12185-011-0996-3/MediaObjects/12185_2011_996_Fig2_HTML.gif
         isPartOf:
            name:International Journal of Hematology
            issn:
               1865-3774
               0925-5710
            volumeNumber:95
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Japan
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Gorica Nikoloski
               affiliation:
                     name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
                     address:
                        name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Bert A. van der Reijden
               affiliation:
                     name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
                     address:
                        name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joop H. Jansen
               affiliation:
                     name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
                     address:
                        name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Mutations in epigenetic regulators in myelodysplastic syndromes
      description:Until recently, the genetic aberrations that are causally linked to the pathogenesis of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms were largely unknown. Using novel technologies like high-resolution SNP-array analysis and next generation sequencing, various genes have now been identified that are recurrently mutated. Strikingly, several of the newly identified genes (ASXL1, DNMT3A, EZH2, IDH1 and IDH2, and TET2) are involved in the epigenetic regulation of gene expression. Aberrant epigenetic modifications have been described in many types of cancer, including myeloid malignancies. It has been proposed that repression of genes that are crucial for the cessation of the cell cycle and induction of differentiation might contribute to the malignant transformation of normal hematopoietic cells. Several therapies that aim to re-express silenced genes are currently being tested in MDS, like histone deacetylase inhibitors and hypomethylating agents. It will be interesting to assess whether patients carrying mutations in epigenetic regulators respond differently to these novel forms of epigenetic therapies.
      datePublished:2012-01-11T00:00:00Z
      dateModified:2012-01-11T00:00:00Z
      pageStart:8
      pageEnd:16
      sameAs:https://doi.org/10.1007/s12185-011-0996-3
      keywords:
         Myelodysplastic syndromes
         Mutations
         Epigenetic regulators
         Epigenetic therapy
         Hematology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12185-011-0996-3/MediaObjects/12185_2011_996_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12185-011-0996-3/MediaObjects/12185_2011_996_Fig2_HTML.gif
      isPartOf:
         name:International Journal of Hematology
         issn:
            1865-3774
            0925-5710
         volumeNumber:95
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Japan
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Gorica Nikoloski
            affiliation:
                  name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
                  address:
                     name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Bert A. van der Reijden
            affiliation:
                  name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
                  address:
                     name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joop H. Jansen
            affiliation:
                  name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
                  address:
                     name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:International Journal of Hematology
      issn:
         1865-3774
         0925-5710
      volumeNumber:95
Organization:
      name:Springer Japan
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
      address:
         name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
      address:
         name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
      name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
      address:
         name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Gorica Nikoloski
      affiliation:
            name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
            address:
               name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Bert A. van der Reijden
      affiliation:
            name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
            address:
               name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Joop H. Jansen
      affiliation:
            name:Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences
            address:
               name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
      name:Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(224)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.77s.

LINK . SPRINGER . COM {}